p53: from clinical significance to significance in the clinic?
作者信息
Hall A R, Braithwaite A
机构信息
Department of Pathology, Dunedin School of Medicine.
出版信息
N Z Med J. 1997 Sep 26;110(1052):347-8.
PMID:9364174
Abstract
摘要
相似文献
1
p53: from clinical significance to significance in the clinic?p53：从临床意义到临床应用的意义？
N Z Med J. 1997 Sep 26;110(1052):347-8.
2
The p53 tumour suppressor gene and product.p53肿瘤抑制基因及其产物。
Cancer Surv. 1992;12:59-79.
3
p53 as a potential target in cancer therapy.p53作为癌症治疗的潜在靶点。
Bone Marrow Transplant. 1992;9 Suppl 1:164-70.
4
p53 tumor-suppressor gene: clues to molecular carcinogenesis.p53肿瘤抑制基因：分子致癌作用的线索
J Cell Physiol. 1997 Nov;173(2):247-55. doi: 10.1002/(SICI)1097-4652(199711)173:2<247::AID-JCP30>3.0.CO;2-A.
5
[TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].[TP53肿瘤抑制基因：20年后（以及一万种突变之后）]
Bull Cancer. 2000 Jan;87(1):11-8.
6
Oncogenes in tumors of gallbladder and biliary tract.胆囊和胆道肿瘤中的癌基因。
Fukuoka Igaku Zasshi. 2004 Feb;95(2):31-5.
7
[Clinical significance of p53 antibody].[p53抗体的临床意义]
Nihon Rinsho. 2001 Oct;59 Suppl 6:356-61.
8
[TP53 mutations and molecular epidemiology].[TP53 突变与分子流行病学]
Gan To Kagaku Ryoho. 2007 May;34(5):683-9.
9
p53: it has it all, but will it make it to the clinic as a marker in bladder cancer?p53：它具备一切，但它会作为膀胱癌的一个标志物进入临床应用吗？
J Clin Oncol. 2007 Dec 1;25(34):5341-4. doi: 10.1200/JCO.2007.13.1904.
10
[Environmental carcinogens and p53 gene mutation].[环境致癌物与p53基因突变]
Wei Sheng Yan Jiu. 2004 Mar;33(2):239-43.
Zotero 插件